When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion in sales in 2023, it shows no ...

Skipping certain foods can help patients manage nausea and other side effects of the popular drugs, doctors say.

The drugs were first approved to treat type 2 diabetes – and that's what the FDA said daily injections of liraglutide could ...

Semaglutide, the active ingredient in Ozempic and Wegovy, has been linked to a condition that can cause permanent vision loss ...

“Among adults, 5.4% of all prescriptions in September 2024 were for GLP-1s,” Rodriguez says. That is up from 3.5% a year ...

And according to some doctors, some of their patients have said they want to ... GLP-1 receptor agonists and dual agonists – such as Ozempic, Wegovy, Mounjaro and Zepbound – are typically ...

To avoid getting drunk quickly - and to skip hangovers - most of us know it’s ... the pharmaceutical company that manufactures Ozempic and Wegovy, says “Patient safety is of the utmost ...

Nearly half of US adults admit they’d take one of the newer, injectable weight loss drugs, but that number falls ...

Investing.com -- Shares of Novo Nordisk (NYSE: NVO) A/S, the Danish pharmaceutical company, experienced a significant drop ...